申请人:THE UNIVERSITY OF KANSAS
公开号:EP2502624A1
公开(公告)日:2012-09-26
The present invention provides compounds according to the Formula I:
wherein R1 is carboxyl, acryl, or carboxylic acid hydrazide, but is not -COOH; wherein R2 is at the 6-position and is halogen, alcohol, alkyl, alkoxy, aralkyl, cycloalkyl, haloalkyl, haloalkoxy, amino, or carboxyl; wherein X and Y are the same or different from each other and are halogen or lower alkyl; wherein Z1, Z2, Z3, and Z4 are carbon, and pharmaceutically salts and esters thereof.
The invention further provides pharmaceutical preparations comprising such compounds and such preparations for use in the inhibition of spermatogenesis or in the treatment of cancer.
本发明提供了根据式I的化合物:其中R1是羧基、丙烯酰基或羧酸酰肼,但不是-COOH;其中R2位于6位,并且是卤素、醇、烷基、烷氧基、芳烷基、环烷基、卤代烷基、卤代烷氧基、氨基或羧基;其中X和Y彼此相同或不同,并且是卤素或低级烷基;其中Z1、Z2、Z3和Z4是碳,以及其药用盐和酯。 本发明进一步提供了包含此类化合物的药物制剂以及用于抑制精子发生或治疗癌症的此类制剂。